A new CHEST framework sets out six steps for building lung nodule programs, carrying patients reliably from first detection to diagnosis, with validated biomarker testing built into the pathway.
Oral small-molecule weight-loss drugs are set to take centre stage ahead of ObesityWeek 2026, as new chronic weight management data promises a simpler, more scalable era of obesity treatment.
